BBIO
BridgeBio Pharma, Inc.
$78.01+1.21 (+1.58%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Jun 27, 2019 – Nov 18, 2026, Dividends reinvested
- Final balance
- $28,316
- CAGR
- +15.11%
- Max drawdown
- −92.80%
Trailing returns (%)
BBIO's average annual return was 11.69% over the last 5 years, through Nov 18, 2026. $10,000 in BBIO on Nov 18, 2021 grew to $17,378 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +17.50%
- 3M
- −5.99%
- 6M
- +19.43%
- YTD
- +1.99%
- 1Y
- +18.94%
Per year
- 3Y
- +38.68%
- 5Y
- +11.69%
- Since 2019
- +15.11%
Annual returns
2019 from Jun 27 · 2026 through Nov 18
BBIO returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +1.99% |
| 2025 | +178.75% |
| 2024 | −32.03% |
| 2023 | +429.79% |
| 2022 | −54.32% |
| 2021 | −76.54% |
| 2020 | +102.88% |
| 2019 from Jun 27 | +27.22% |
Metrics
Since 2019| Volatility | 81.78% |
|---|---|
| Sharpe ratio | 0.61 |
| Sortino ratio | 0.95 |
| Calmar ratio | 0.16 |
| Longest drawdown | 4.8 years |
Worst drawdowns
Since 2019| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −92.8% | Feb 2021 | May 2022 | Dec 2025 | 4.8 years |
| −65.5% | Dec 2019 | Mar 2020 | Nov 2020 | 11 months |
| −44.5% | Sep 2019 | Oct 2019 | Nov 2019 | 3 months |
| −29.8% | Jul 2026 | Oct 2026 | Not yet | 4 months so far |
| −22.0% | Dec 2020 | Jan 2021 | Feb 2021 | 1 month |